Newly Engineered “Mimic” Nanoparticles to Aid Cancer Treatment Say Researchers at Nano Med Tech

Nanoparticles “impersonating” red blood cells will be able to fool the immune system and deliver their payload of cancer-disolving drugs directly to a tumor, say researchers at Shanghai’s Nano Med Tech.

The researchers, led by Dr. Xiao Yan Fat, say that they have developed a method that of taking the membrane off of a red blood cell and wrapping it like a disguise around a biodegradable nanoparticle packing with a specific dose of molecular drugs. The ability to deliver multiple drugs in a single nanoparticle is vital because, as Dr. Fat stressed, “Cancerous cells tend to rapidly grow a resistance to drugs that are delivered to the area one at a time.”

“Red blood cells are able to circulate around the body for approximately six months. This will allow these disguised nanparticles to do the same, all the while delivering measured dosages to particularly targeted areas. The immune system will not even know that a foreign body is about, and thus will never attack. To say that this kind of medicinal delivery system is a leap forward, could almost be considered an understatement,” the doctor concluded.

Nano Med Tech is a biomedical research organization with its primary facility in Shanghai, China. The organization focuses on human application of nano-technology, particularly in the field of cancer treatment. To view the new Nano Med Tech website, visit www.nanomedtech-china.com.

Nano Med Tech,
1001 Tian Lin Road
Caohejin Hi-Tech Park,
Shanghai,
China 200233

admin@nanomedtech-china.com

This release was published on openPR.